Short Summary
The Court of Appeal of the Unified Patent Court declared an appeal inadmissible for lack of prior authorization from the Court of First Instance. Photon Wave had appealed a procedural order (ORD_41423/2024) issued by the Paris Local Division in proceedings concerning EP 3 404 726, but the Court of First Instance had merely included a general reference to Rule 220.2 RoP without expressly granting leave to appeal. The Court of Appeal held that such authorization must be expressly granted and cannot be presumed.
Detailed Summary
This procedural order concerns an appeal (CoA_PC 01/2024) filed by Photon Wave Co., Ltd against order ORD_41423/2024 rendered on July 24, 2024 by the Paris Local Division of the Court of First Instance in main proceedings ACT_588685/2023 (UPC_CFI_440/2023). The patent in dispute is EP 3 404 726. Photon Wave, a Korean company, was the intervenor in the first instance proceedings, while Seoul Viosys Co., Ltd., also a Korean company, was the claimant.
On August 2, 2024, Photon Wave filed its notice of appeal. On September 5, 2024, Seoul Viosys submitted its response and raised an objection of inadmissibility, arguing that the appeal had not been authorized by the Court of First Instance as required by Rule 220.2 RoP. By order of the judge-rapporteur dated September 16, 2024, Photon Wave was authorized to submit written observations on this inadmissibility objection, to which it responded on September 24, 2024.
The Court of Appeal examined the admissibility of the appeal under Article 73 of the Agreement on a Unified Patent Court (UPCA) and Rule 220.2 of the Rules of Procedure. It held that, outside the case of an appeal filed together with an appeal of the final decision, the authorization to appeal under Rule 220.2 must be expressly granted by the Court and cannot be presumed. In the absence of such express authorization, the appeal is inadmissible, without prejudice to a possible discretionary review request under Rule 220.3 RoP or the possibility of appealing the order together with an appeal of the final decision.
In the present case, the Court of First Instance had merely stated, using general terms at the end of the operative part of the contested order, that the order 'is subject to appeal under the conditions provided by the provisions of R. 220.2 RoP.' The Court of Appeal found that this amounted only to an informative reference to the applicable procedural rules and did not constitute an express grant of authorization to appeal. If the Court had intended to grant such authorization, it would have used explicit language such as 'the authorization to appeal is granted,' as contemplated by Article 73 UPCA. The Court of Appeal further noted that the contested order was consistent with the standard template for orders available on the Unified Patent Court's website, which contains a general formula regarding the conditions under which an appeal may be filed.
The Court of Appeal rejected Photon Wave's contention that the appeal had been 'admitted,' finding that Photon Wave had failed to justify this assertion. The Court also noted that this conclusion was consistent with its prior order of March 14, 2024 in the case of Abbott v. Dexcom (UPC_CoA_5/2024, PR_APL_189/2024). Finally, the Court held that, as this was a formal matter falling within the examination under Rule 229 RoP, and after having allowed both parties to submit written observations, there was no need to hold an oral hearing.
The Court of Appeal therefore declared the appeal inadmissible, without needing to rule on the other requests.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Luxembourg (LU). Understanding the court's reasoning in Photon Wave Co., Ltd vs Seoul Viosys Co., Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Guardant Health, Inc.vsSophia Genetics SA, Sophia Genetics SAS, Sophia Genetics SRL, Sophia Genetics GmbH
Guardant Health, Inc. sought provisional measures before the Paris Local Division against the Sophia Genetics group, alleging infringement of four European patents relating to liquid biopsy technology by the 'MSK-ACCESS® powered with SOPHiA DDM' test. The Court rejected the application, finding that EP'073 contained added matter over its original PCT application, and that Guardant Health failed to demonstrate infringement of EP'066 and EP'986 with a sufficient degree of certainty. Guardant Health was ordered to pay Sophia Genetics 400,000 euros in interim costs.
TGI Sport Suomi Oy (formerly Supponor Oy), TGI Sport Virtual Limited (formerly Supponor Limited), Supponor SASU, TGI Sport Italia S.r.l. (formerly Supponor Italia S.r.l.), and Supponor España SLvsAIM Sport Development AG
This appeal concerned orders of the Helsinki Local Division granting AIM Sport Development AG leave to amend its Statement of claim under R. 263 RoP and to add TGI Sport Virtual UK Limited as a new defendant under R. 305 RoP in a patent infringement action. The appellants (TGI entities) challenged the orders on grounds of inadmissibility and procedural unfairness. The Court of Appeal dismissed the appeal, holding that the Local Division had properly exercised its discretion and that the scope of review on appeal regarding such discretionary decisions is limited.
Curio Bioscience Inc.vs10x Genomics, Inc.
Unified Patent Court decision.
Edwards Lifesciences CorporationvsMeril Italy srl
Unified Patent Court decision.
Huawei Technologies Co. Ltd.vsSercomm Corporation, SerComm Deutschland GmbH, Sercomm France SARL, Sercomm Italia SRL
Procedural order from the Local Chamber Munich of the Unified Patent Court concerning a patent infringement action filed by Huawei Technologies against four Sercomm entities. The order, issued following an early interim hearing under Rule 105.5 RoP, sets dates for a further interim hearing and oral hearing, and addresses procedural matters including service, defense strategy, and potential separation of proceedings. The dispute concerns alleged indirect and direct infringement of European Patent EP 3 611 989 B1, which Huawei asserts is essential for WiFi6.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.